Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Vandetanib for the treatment of medullary thyroid cancer.

Chau NG, Haddad RI. Vandetanib for the treatment of medullary thyroid cancer. Clin Cancer Res. 2013 Feb 01; 19(3):524-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.